UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

NIDA's medication development priorities in response to the Opioid Crisis: ten most wanted

Neuropsychopharmacology (New York, N.Y.), 2019-03, Vol.44 (4), p.657-659

2019

Volltextzugriff (PDF)

Synopsis of Expert Opinions and Conclusions

CNS & neurological disorders drug targets, 2015-01, Vol.14 (6), p.773-776

2015

Volltextzugriff (PDF)

The mGlu5 receptor negative allosteric modulator mavoglurant reduces escalated cocaine self-administration in male and female rats

Psychopharmacology (Berlin, Germany), 2024-06

2024

Volltextzugriff (PDF)

From bench to bedside: mGluR2 positive allosteric modulators as medications to treat substance use disorders

Psychopharmacology, 2017-05, Vol.234 (9-10), p.1347-1355

2017

Volltextzugriff (PDF)

Evidence for the contribution of D4 receptors to cocaine self-administration in monkeys

Drug and alcohol dependence, 2014-07, Vol.140, p.e3-e3

Acri, Jane B

2014

Volltextzugriff (PDF)

Dopamine D3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs

The Journal of pharmacology and experimental therapeutics, 2015-09, Vol.354 (3), p.484

2015

Volltextzugriff (PDF)

Introduction to a Symposium on Recent Advances in the Development of Medications for Drug Abuse Treatment in Honor of Jack H. Mendelson, MD

Experimental and clinical psychopharmacology, 2008-12, Vol.16 (6), p.443-445

Acri, Jane B

2008

Volltextzugriff (PDF)

Cardiovascular safety of a reversible, selective aldehyde dehydrogenase-2 inhibitor to treat cocaine abuse

Journal of pharmacological and toxicological methods, 2020-09, Vol.105, p.106746, Article 106746

2020

Volltextzugriff (PDF)

Lobeline inhibits the neurochemical and behavioral effects of amphetamine

The Journal of pharmacology and experimental therapeutics, 2001-03, Vol.296 (3), p.1023

2001

Volltextzugriff (PDF)

Cardiovascular safety studies on dopamine D3 receptor antagonists and cocaine

Journal of pharmacological and toxicological methods, 2018-09, Vol.93, p.156-156

2018

Volltextzugriff (PDF)

Biotechnology and the treatment of addictive disorders: new opportunities

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2007-01, Vol.21 (4), p.259-267

2007

Volltextzugriff (PDF)

Summary of NIDA Medications Workshop: New Opportunities for Chemists and Pharmacologists

Drug and alcohol dependence, 2008-01, Vol.92 (1), p.307-311

2008

Volltextzugriff (PDF)

Nicotine modulates effects of stress on acoustic startle reflexes in rats : dependence on dose, stressor and initial reactivity

Psychopharmacologia, 1994-11, Vol.116 (3), p.255-265

ACRI, J. B

1994

Volltextzugriff (PDF)

Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats

Psychopharmacologia, 1994-03, Vol.114 (2), p.369-374

1994

Volltextzugriff (PDF)

Dopamine D 3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs

The Journal of pharmacology and experimental therapeutics, 2015-09, Vol.354 (3), p.484-492

2015

Volltextzugriff (PDF)

Editorial: Emerging Targets for Stimulant Use Disorders: Where To Invest In An Era Of Constrained Resources?

CNS & neurological disorders drug targets, 2015, Vol.14 (6), p.691

2015

Volltextzugriff (PDF)

Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists

The Journal of pharmacology and experimental therapeutics, 1997-10, Vol.283 (1), p.7

1997

Volltextzugriff (PDF)

Presentation Title: Medication Discovery for Drug Addiction Treatment, and the Preclinical Pipeline at NIDA

The Canadian journal of addiction, 2010-12, Vol.1 (3), p.15

Acri, Jane B.

2010

Volltextzugriff (PDF)

A psychophysical task to quantify smoking cessation-induced irritability: The Reactive Irritability Scale (RIS)

Addictive behaviors, 1992-11, Vol.17 (6), p.587-601

1992

Volltextzugriff (PDF)

Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593

Synapse (New York, N.Y.), 2001-03, Vol.39 (4), p.343-350

2001

Volltextzugriff (PDF)

Conceptual and methodological considerations for tobacco addiction research

British Journal of Addiction, 1991-05, Vol.86 (5), p.637-641

1991

Volltextzugriff (PDF)

Strain and age differences in acoustic startle responses and effects of nicotine in rats

Pharmacology, biochemistry and behavior, 1995-02, Vol.50 (2), p.191-198

1995

Volltextzugriff (PDF)

Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors

Synapse (New York, N.Y.), 1998-11, Vol.30 (3), p.275-283

1998

Volltextzugriff (PDF)

Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands

European journal of pharmacology, 1995-08, Vol.281 (2), p.R7-R9

1995

Volltextzugriff (PDF)

Assessment of cocaine-like discriminative stimulus effects of dopamine D 3 receptor ligands

European journal of pharmacology, 1995-08, Vol.281 (2), p.R7-R9

1995

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(36)
Buchkapitel
(1)

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Animals
(14)
Male
(14)
Pharmacology & Pharmacy
(14)
Psychiatry
(10)
Humans
(9)
Neurosciences
(9)
Neurosciences & Neurology
(9)
Rats
(9)
Rats, Sprague-Dawley
(8)
Biological And Medical Sciences
(7)
Medical Sciences
(7)
Dose-Response Relationship, Drug
(5)
Motor Activity - Drug Effects
(5)
Nicotine
(5)
Psychology. Psychoanalysis. Psychiatry
(5)
Acoustic Stimulation
(4)
Nicotine - Pharmacology
(4)
Psychopharmacology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

NIDA's medication development priorities in response to the Opioid Crisis: ten most wanted

Synopsis of Expert Opinions and Conclusions

The mGlu5 receptor negative allosteric modulator mavoglurant reduces escalated cocaine self-administration in male and female rats

From bench to bedside: mGluR2 positive allosteric modulators as medications to treat substance use disorders

Evidence for the contribution of D4 receptors to cocaine self-administration in monkeys

Dopamine D3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs

Introduction to a Symposium on Recent Advances in the Development of Medications for Drug Abuse Treatment in Honor of Jack H. Mendelson, MD

Cardiovascular safety of a reversible, selective aldehyde dehydrogenase-2 inhibitor to treat cocaine abuse

Lobeline inhibits the neurochemical and behavioral effects of amphetamine

Cardiovascular safety studies on dopamine D3 receptor antagonists and cocaine

Biotechnology and the treatment of addictive disorders: new opportunities

Summary of NIDA Medications Workshop: New Opportunities for Chemists and Pharmacologists

Nicotine modulates effects of stress on acoustic startle reflexes in rats : dependence on dose, stressor and initial reactivity

Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats

Dopamine D 3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs

Editorial: Emerging Targets for Stimulant Use Disorders: Where To Invest In An Era Of Constrained Resources?

Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists

Presentation Title: Medication Discovery for Drug Addiction Treatment, and the Preclinical Pipeline at NIDA

A psychophysical task to quantify smoking cessation-induced irritability: The Reactive Irritability Scale (RIS)

Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593

Conceptual and methodological considerations for tobacco addiction research

Strain and age differences in acoustic startle responses and effects of nicotine in rats

Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors

Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands

Assessment of cocaine-like discriminative stimulus effects of dopamine D 3 receptor ligands

Suchergebnisse filtern